News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurotez, Inc., Announced That It Has Contracted with Paragon Bioservices for the Manufacturing of a Leptin Product for the Treatment of Alzheimer's Disease and Other Cognitive Disorders



12/20/2010 9:05:58 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc., announced that it has developed two (2) Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders and has contracted with Paragon Bioservices, Inc. for process optimization and GMP manufacturing of one of these products.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES